SPDR S&P Health Care Equipment ETF Price & Performance (XHE)

Major technology stocks faced losses as skepticism around the AI trend weighed on the market. Palantir dropped over 10%, while Microsoft and Nvidia also saw declines. Analysts suggest the AI sector remains strong, with projections of continued growth over the next few years, despite current investor doubts.1

The healthcare sector remains largely unaffected by recent tariff increases on Canada, Mexico, and China. Pharmaceutical and medical device companies have limited dependence on these regions. However, stakeholders are advised to monitor potential risks as the industry navigates broader economic uncertainties.2

Henry Schein stock has risen 11.6% year-to-date, outperforming the S&P 500. The stock's surge follows a significant investment by KKR & Co., which acquired a stake and plans further funding. Analysts maintain a "Moderate Buy" rating, highlighting both growth potential and lingering uncertainties like tariff impacts.3